Structural Basis of Zika Virus-Specific Antibody Protection.
about
The FDA-approved drug sofosbuvir inhibits Zika virus infectionZika and pregnancy: A comprehensive reviewProlonged Detection of Zika Virus in Vaginal Secretions and Whole BloodIdentifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus SpeciesA Multiplex Microsphere Immunoassay for Zika Virus DiagnosisNeuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I InterferonZika virus: from pathogenesis to disease controlFuture developments in biosensors for field-ready Zika virus diagnosticsZika Virus Pathogenesis and Tissue TropismA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisEvaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous SystemThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisA human antibody against Zika virus crosslinks the E protein to prevent infectionLack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus InfectionPotential mechanisms of Zika-linked microcephalyMaternal-Fetal Transmission of Zika Virus: Routes and Signals for InfectionVaccination strategies against Zika virusHumoral cross-reactivity between Zika and dengue viruses: implications for protection and pathologyTransposon mutagenesis of the Zika virus genome highlights regions essential for RNA replication and restricted for immune evasion.Zika virus-like particle (VLP) based vaccineCharacterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.Prospects for a Zika Virus Vaccine.Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?Delineating antibody recognition against Zika virus during natural infectionRapid development of a DNA vaccine for Zika virusZika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice.Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus.Monoclonal antibodies against Zika virus: Therapeutics and their implications for vaccine design.DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.Zika Virus: Immunity and Vaccine Development.Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?Zika virus has oncolytic activity against glioblastoma stem cells.Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections.
P2860
Q27924226-A1EC2F6E-B644-49A0-9F93-1DC8D1C302B1Q27924233-C489355F-0A26-4F7B-B8CA-0F8E989AC8CCQ28114599-4475370F-D5B4-47EE-BA01-BB3054BB34D9Q28119651-A0AB3AA4-3AA7-4E5D-86ED-73B2EC69988AQ28223265-37C9E0CE-EB1A-456A-AF71-6735D428C8EFQ28223446-686AD657-CAC3-4B85-B570-D1681CC7EE1AQ28278045-A389BB68-3190-4B81-A96C-5DFD1CF318CAQ28577936-16E9EFB7-1CF5-43F5-93BA-F545DE29E5E8Q28733400-6C26FFBE-7EA2-471C-992F-D41849C992A6Q28804076-4D8BE19A-BE04-46EA-A073-7697ED0ABD95Q28804198-5F93DCDB-66C0-43EE-8735-CE63457B4BF4Q28804225-B84FAC91-1568-46E4-A17C-4167E79F40CDQ28950443-4D5CBBE7-26E6-4FFB-9052-812EFAE8EC89Q29051494-97D1892A-A032-4051-8D6B-3F6EDF4A369BQ29364523-AF4C8041-243D-4819-B8A1-739F16CB865AQ29451356-1DDFBBC3-9A29-4454-997D-82B661F7DD54Q29571224-F5057C30-9887-4D31-BB95-8339DB388D3DQ29994510-FD4226E7-429A-452F-8545-A7D9005EAEF1Q30145598-0746DDBF-670B-4117-93BF-6B297801CBD5Q30145640-EF48C7D3-6C6F-4C78-93BA-84DAAFD815C0Q30145645-56826DEF-8DFD-444C-805D-0C4E63854D45Q30235612-5836C221-8565-4658-B844-6E62C8FB83E0Q30238657-2DA5038B-3697-4679-8DEA-A30B87D81902Q33681310-267C8342-B5C0-4824-B0D0-C0F769977EFDQ33715238-4A608AF9-D308-4A68-A8D0-38225CD7DA19Q33798068-35E04311-3108-4025-904D-8E120AB086D0Q34542032-7268936D-6615-47D5-B158-248C4DB437D8Q38156674-BA82E004-9A3C-4081-A6A6-7F6C7FDEB407Q38156841-8162D512-DEC2-4316-A489-CDBBF11A7ED3Q38156855-674080C7-C69E-435F-B458-BF9ACF6F8BA0Q38157121-801F3EE1-8A1B-4570-B4E4-F59DA63ACD41Q38157397-9EE0628A-A958-4EF7-868F-DFA7F6DE0DB3Q38157816-13C46992-3D36-424A-8B32-72B9801A733EQ38157833-EDFCA65A-9A2D-42CE-858A-B2697EDD8833Q38158247-5142CAD8-FD25-46F6-A13B-E25B37601B63Q38782718-37000A26-44D8-48A4-8510-DBD823E673DCQ38969772-A2CF4135-2820-425F-8F87-C2B8F9D21072Q40037723-3E9E5589-D2D6-4018-8A52-3ADFD90A9408Q40037821-C1B9490D-15AA-423A-9A6C-C7BE37AB6003Q40047603-7E977E39-F386-4671-99B8-E7ECDAC95FD1
P2860
Structural Basis of Zika Virus-Specific Antibody Protection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Structural Basis of Zika Virus-Specific Antibody Protection.
@en
type
label
Structural Basis of Zika Virus-Specific Antibody Protection.
@en
altLabel
Structural Basis of Zika Virus-Specific Antibody Protection
@en
prefLabel
Structural Basis of Zika Virus-Specific Antibody Protection.
@en
P2093
P2860
P50
P1433
P1476
Structural Basis of Zika Virus-Specific Antibody Protection.
@en
P2093
Christopher A Nelson
Daved H Fremont
Haiyan Zhao
Jennifer Govero
Matthew J Gorman
Scott D Speer
P2860
P304
P356
10.1016/J.CELL.2016.07.020
P407
P577
2016-07-26T00:00:00Z